Evidence that p38 mitogen-activated protein kinase contributes to neonatal hypoxic-ischemic brain injury

被引:14
作者
Han, BH
Choi, J
Holtzman, DM
机构
[1] Washington Univ, Sch Med, Dept Neurol, Ctr Study Nervous Syst Injury, St Louis, MO 63110 USA
[2] Ewha Womans Univ, Coll Pharm, Dept Pharm, Seoul, South Korea
关键词
p38; mitogen-activated protein kinase; hypoxia-ischemia; neurodegeneration; apoptosis; caspase-3; neuroprotection;
D O I
10.1159/000069046
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
We tested the response of stress-activated mitogen-activated protein kinases (MAPKs) - p38 MAPK and c-JUN NH2-terminal kinase (JNK) -following hypoxia-ischemia (H-I) induced by unilateral carotid artery ligation and hypoxia (8% O-2 and 92% N-2) for 2.5 h in postnatal-day-7 rats. Phosphorylation of p38 MAPK increased in the hippocampus and cortex immediately following H-I and returned to a basal level 6 h later. In contrast to p38 MAPK, phosphorylation of JNK decreased in the hippocampus and cortex immediately following H-I. Intracerebroventricular administration of two different p38 MAPK inhibitors prior to H-I significantly protected the neonatal brain from H-I injury. Interestingly, p38 MAPK inhibitors did not attenuate caspase-3 activation 24 h after H-I. Thus, these data suggest that p38 MAPKs contribute to the rapid, early component of brain injury following neonatal H-I. Copyright (C) 2002 S. Karger AG, Basel.
引用
收藏
页码:405 / 410
页数:6
相关论文
共 38 条
[1]   BDNF protects against spatial memory deficits following neonatal hypoxia-ischemia [J].
Almli, CR ;
Levy, TJ ;
Han, BH ;
Shah, AR ;
Gidday, JM ;
Holtzman, DM .
EXPERIMENTAL NEUROLOGY, 2000, 166 (01) :99-114
[2]  
Barone FC, 2001, J PHARMACOL EXP THER, V296, P312
[3]   Synergistic activation of caspase-3 by m-calpain after neonatal hypoxia-ischemia - A mechanism of "pathological apoptosis"? [J].
Blomgren, K ;
Zhu, CL ;
Wang, XY ;
Karlsson, JO ;
Leverin, AL ;
Bahr, BA ;
Mallard, C ;
Hagberg, H .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (13) :10191-10198
[4]   Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and -independent mechanisms [J].
Bonni, A ;
Brunet, A ;
West, AE ;
Datta, SR ;
Takasu, MA ;
Greenberg, ME .
SCIENCE, 1999, 286 (5443) :1358-1362
[5]   Caspase inhibitor affords neuroprotection with delayed administration in a rat model of neonatal hypoxic-ischemic brain injury [J].
Cheng, Y ;
Deshmukh, M ;
D'Costa, A ;
Demaro, JA ;
Gidday, JM ;
Shah, A ;
Sun, YL ;
Jacquin, MF ;
Johnson, EM ;
Holtzman, DM .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (09) :1992-1999
[6]   SELECTIVE SPARING OF NADPH-DIAPHORASE NEURONS IN NEONATAL HYPOXIA-ISCHEMIA [J].
FERRIERO, DM ;
ARCAVI, LJ ;
SAGAR, SM ;
MCINTOSH, TK ;
SIMON, RP .
ANNALS OF NEUROLOGY, 1988, 24 (05) :670-676
[7]  
Han BH, 2000, NEUROBIOL DIS, V7, P38
[8]   BDNF protects the neonatal brain from hypoxic-ischemic injury in vivo via the ERK pathway [J].
Han, BH ;
Holtzman, DM .
JOURNAL OF NEUROSCIENCE, 2000, 20 (15) :5775-5781
[9]   Selective, reversible caspase-3 inhibitor is neuroprotective and reveals distinct pathways of cell death after neonatal hypoxic-ischemic brain injury [J].
Han, BH ;
Xu, DG ;
Choi, JJ ;
Han, YX ;
Xanthoudakis, S ;
Roy, S ;
Tam, J ;
Vaillancourt, J ;
Colucci, J ;
Siman, R ;
Giroux, A ;
Robertson, GS ;
Zamboni, R ;
Nicholson, DW ;
Holtzman, DM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (33) :30128-30136
[10]   Clusterin contributes to caspase-3-independent brain injury following neonatal hypoxia-ischemia [J].
Han, BH ;
DeMattos, RB ;
Dugan, LL ;
Kim-Han, JS ;
Brendza, RP ;
Fryer, JD ;
Kierson, M ;
Cirrito, J ;
Quick, K ;
Harmony, JAK ;
Aronow, BJ ;
Holtzman, DM .
NATURE MEDICINE, 2001, 7 (03) :338-343